A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-26
DOI
10.1038/s41380-022-01745-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease
- (2022) Guillaume Tremblay et al. CRISPR Journal
- ENGAGE and EMERGE: Truth and consequences?
- (2021) Lewis H. Kuller et al. Alzheimers & Dementia
- Trends in peptide drug discovery
- (2021) Markus Muttenthaler et al. NATURE REVIEWS DRUG DISCOVERY
- Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents
- (2021) Zhi Du et al. ACCOUNTS OF CHEMICAL RESEARCH
- History in perspective: How Alzheimer's Disease came to be where it is?
- (2021) Tehniat F. Ahmed et al. BRAIN RESEARCH
- NMDA and AMPA receptors dysregulation in Alzheimer's disease
- (2021) Parvin Babaei EUROPEAN JOURNAL OF PHARMACOLOGY
- Amyloid‐beta 1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus
- (2020) Jason H.Y. Yeung et al. JOURNAL OF NEUROCHEMISTRY
- Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer’s disease
- (2020) Taisia Rolova et al. Stem Cell Research
- Learning and reaction times in mouse touchscreen tests are differentially impacted by mutations in genes encoding postsynaptic interacting proteins SYNGAP1 , NLGN3 , DLGAP1 , DLGAP2 and SHANK2
- (2020) Alexa E. Horner et al. GENES BRAIN AND BEHAVIOR
- Recent Progress on the Drug Development for the Treatment of Alzheimer’s Disease Especially on Inhibition of Amyloid-Peptide Aggregation
- (2020) Yuanyuan Liu et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer’s Disease in SH-SY5Y cells
- (2020) Antoine Guyon et al. PLoS One
- Predictions of Alzheimer’s disease treatment and care costs in European countries
- (2019) Richard Cimler et al. PLoS One
- The discovery and development of inhaled therapeutics for migraine
- (2019) Nicolas Vandenbussche et al. Expert Opinion on Drug Discovery
- Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
- (2019) D. J. Marciani Research
- Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
- (2019) Joseph F. Arboleda-Velasquez et al. NATURE MEDICINE
- Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
- (2019) Marcella Catania et al. Frontiers in Aging Neuroscience
- Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?
- (2018) Ramón Cacabelos Expert Opinion on Drug Discovery
- Translational Research in Alzheimer’s and Prion Diseases
- (2018) Giuseppe Di Fede et al. JOURNAL OF ALZHEIMERS DISEASE
- Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
- (2018) Mukta Agrawal et al. JOURNAL OF CONTROLLED RELEASE
- Intranasal insulin in Alzheimer's disease: Food for thought
- (2018) Colin D. Chapman et al. NEUROPHARMACOLOGY
- Molecular subtypes of Alzheimer’s disease
- (2018) Giuseppe Di Fede et al. Scientific Reports
- The Intranasal Route as an Alternative Method of Medication Administration
- (2018) Calvin Tucker et al. Critical Care Nurse
- Molecular dynamics simulation on the effect of transition metal binding to the N-terminal fragment of amyloid-β
- (2018) Matthew Turner et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
- (2018) Piyoosh Sharma et al. PROGRESS IN NEUROBIOLOGY
- Alzheimer's disease
- (2017) C. A. Lane et al. EUROPEAN JOURNAL OF NEUROLOGY
- Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015
- (2017) Dev Mehta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”
- (2017) John Hardy FEBS Journal
- GluA1 subunit ubiquitination mediates amyloid-β-induced loss of surface α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
- (2017) Sumasri Guntupalli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer’s Disease
- (2017) Deepti Goyal et al. ACS Combinatorial Science
- Alzheimer’s amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity
- (2017) Tien-Wei Lin et al. PLoS One
- Role of the N-terminus for the stability of an amyloid-β fibril with three-fold symmetry
- (2017) Christian A. Söldner et al. PLoS One
- The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study
- (2017) Laura Cantu’ et al. Scientific Reports
- Alzheimer’s disease: experimental models and reality
- (2016) Eleanor Drummond et al. ACTA NEUROPATHOLOGICA
- Dimerization Mechanism of Alzheimer Aβ40 Peptides: The High Content of Intrapeptide-Stabilized Conformations in A2V and A2T Heterozygous Dimers Retards Amyloid Fibril Formation
- (2016) Phuong H. Nguyen et al. JOURNAL OF PHYSICAL CHEMISTRY B
- The new β amyloid-derived peptide Aβ1–6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity
- (2016) Luisa Diomede et al. NEUROBIOLOGY OF DISEASE
- The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt
- (2016) Sara Cimini et al. NEUROBIOLOGY OF DISEASE
- Dysfunction of NMDA receptors in Alzheimer’s disease
- (2016) Yan Zhang et al. NEUROLOGICAL SCIENCES
- Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
- (2016) Giuseppe Di Fede et al. Scientific Reports
- Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration
- (2015) Jeffrey J Lochhead et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Rationally Designed Peptidomimetic Modulators of Aβ Toxicity in Alzheimer's Disease
- (2015) K. Rajasekhar et al. Scientific Reports
- Inhibition of Amyloid-β Aggregation in Alzheimer's Disease
- (2014) Qiuming Wang et al. CURRENT PHARMACEUTICAL DESIGN
- The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1–42 Molecular Assembly
- (2014) Massimo Messa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
- (2014) Janice A. Maloney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-β (Aβ) Aggregation
- (2014) Iryna Benilova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?
- (2014) Rafael Franco et al. Frontiers in Pharmacology
- Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity
- (2013) Luisa Diomede et al. NEUROBIOLOGY OF DISEASE
- Oral biodrug delivery using cell-penetrating peptide
- (2012) El-Sayed Khafagy et al. ADVANCED DRUG DELIVERY REVIEWS
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population
- (2012) Mia Kero et al. NEUROBIOLOGY OF AGING
- Good gene, bad gene: New APP variant may be both
- (2012) Giuseppe Di Fede et al. PROGRESS IN NEUROBIOLOGY
- Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease
- (2011) Charles Y. Shao et al. ACTA NEUROPATHOLOGICA
- High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain
- (2011) Harry D. Samaroo et al. JOURNAL OF NEUROSCIENCE METHODS
- A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis
- (2009) G. Di Fede et al. SCIENCE
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
- (2008) Leah R Hanson et al. BMC NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now